Journal of Chemistry

Journal of Chemistry / 2010 / Article

Open Access

Volume 7 |Article ID 293287 | 7 pages |

Template Synthesis, Characterization and Biological Activity of Cu(II), Ni(II), Co(II), Zn(II)Complexes with Isonicotinoylhydrazone--2-aldehydefluorene Ligand

Received30 May 2009
Accepted20 Jul 2009


This is about synthesizing new complex combinations of Cu(II), Ni(II),Co(II), Zn(II) with aroylhydrazone ligand isonicotinoylhydrazone-2-aldehydefluorene (INHAF) made by condensation of isonicotinoylhydrazine with 2-aldehydefluorene. The complexes have been characterized by analytical data, IR, UV-Vis, NMR spectra, magnetic susceptibility values, thermal analysis and for the Cu(II) complex the ESR spectrum has been registered. For all complexes the biological activity against the Staphylo-coccus aureus, Escherichia coli, Klebssiella pneumoniae bacteria has been investigated. The experimental data sustain stoichiometry of 1:2 (metal/ligand) for the Cu(II), Ni(II), Zn(II) complexes and of 1:1 for the complex with Co(II). The electronic spectra and the magnetic moments suggest octahedral stereochemistry at the complexes with Cu(II), Ni(II) and the tetrahedral geometry for the Co(II) complex. The INHAF ligand is coordinated bidentate by the O=C amide oxygen and the azomethine nitrogen in the complexes of Cu(II), Ni(II), Co(II) and monodentate by the azomethine nitrogen in the complex of Zn(II).

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

337 Views | 567 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.